Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 100 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
991 11.6 months Advanced colorectal 5 Chemotherapy
Southampton General Hospital United Kingdom 8/2006
Treatment Details: Patients: This phase II study involved 22 patients with advanced colorectal cancer. The median age was 64, ranging from 27 to 75 years. Fifteen were men and seven were women. Treatment
 
992 11.6 months Advanced or metastatic NSCLC 4 Chemotherapy
UCT-University Cancer Center Germany 2/2013
Treatment Details: Patients: This phase 2 study involved advanced or metastatic non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 43 patients with a median
 
993 11.6 months Epithelial ovarian cancer and primary peritoneal cancer 4 Biologic therapy
University of Colorado Denver United States 10/2011
Treatment Details: Patients: This phase II study involved 54 women with previously treated epithelial ovarian cancer or primary peritoneal cancer. The median patient age was 62 years. Treatment: Patients
 
994 11.6 months Metastatic hepatocellular carcinoma 4 Biologic therapy
Princess Margaret Hospital Canada 1/2008
Treatment Details: Patients: This phase II study involved 15 metastatic hepatocellular carcinoma patients who had no prior systemic chemotherapy. The median patient age was 57 years and 93% were male. Tre
 
995 11.5 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Hormone
CRCUM-Universite de Montreal Canada 9/2011
Treatment Details: Patients: This study involved men with metastatic castrate-resistant prostate cancer previously treated with docetaxel. Patients were divided into two separate treatment groups. Group A c
 
996 11.5 months NHL 5 Chemotherapy
Medical University of Lublin Poland 1/2014
Treatment Details: Patients: This involved 92 patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia. The median patient age was 61 years and 64 were men. Treatment: Patients were treated wit
 
997 11.5 months Non-Squamous NSCLC 5 Chemotherapy
Hospital Universitario Doce de Octubre Spain 3/2015
Treatment Details: Patients: This phase 3 study involved untreated advanced non-squamous non- small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 315 pat
 
998 11.5 months NSCLC 5 Biologic therapy
National Kyushu Cancer Center Japan 9/2008
Treatment Details: Patients: This phase III study involved 489 patients with non-small cell lung cancer. The majority (about 62%) were men. About 44% were 65 years of age or older. Treatment: Patients w
 
999 11.5 months Advanced NSCLC 4 Chemotherapy
Zhejiang University China 4/2006
Treatment Details: Patients: This Phase II trial involved a total of 54 patients with advanced non-small-cell lung cancer. There were 44 men and 10 women. The median age was 63. Thirteen patients had squamo
 
1000 11.5 months advanced hepatocellular carcinoma 4 Chemotherapy
Groupe Hospitalier Pitie Salpetriere France 3/2007
Treatment Details: Patients: This phase II study involved 34 patients with advanced liver cancer. Of these, 13 had underlying alcoholic liver disease and 21 did not. The median age of these patients was 59 y
 
Page 100 of 187  | Previous Page  | Next Page